1. P4‐381: A Two‐Part, Double‐Blind, Placebo‐Controlled, Phase 1 Study of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of CT1812 in Healthy Volunteers. (1st July 2016) Authors: Catalano, Susan; Grundman, Michael; Schneider, Lon S.; DeKosky, Steven; Morgan, Roger; Higgin, Michelle; Pribyl, Julie; Mozzoni, Kelsie; Izzo, Nicholas J.; Safferstein, Hank; Lickliter, Jason Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2014)Part 24 Page Start: P1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-18. A PHASE IB/II CLINICAL TRIAL OF DODECAFLUOROPENTANE EMULSION (DDFPE) AS A RADIOSENSITIZER IN GLIOBLASTOMA. (11th November 2019) Authors: Lickliter, Jason; Ruben, Jeremy; Jennens, Ross; Kichenadasse, Ganessan; Gzell, Cecelia; Mason, Ralph; Carmody, Raymond; Becker, Jennifer; Stea, Baldassarre; Zhou, Heling; Sellenger, Michael; Longacre, Olivia; Graham, Kaitlin; Unger, Evan Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β-lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β-lactamases. (4th October 2017) Authors: Lickliter, Jason; Lawrence, Kenneth; O'Donnell, John; Isaacs, R Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial. Issue 11 (November 2022) Authors: Mallory, Raburn M; Formica, Neil; Pfeiffer, Susan; Wilkinson, Bethanie; Marcheschi, Alex; Albert, Gary; McFall, Heather; Robinson, Michelle; Plested, Joyce S; Zhu, Mingzhu; Cloney-Clark, Shane; Zhou, Bin; Chau, Gordon; Robertson, Andreana; Maciejewski, Sonia; Hammond, Holly L; Baracco, Lauren; Lo... Journal: Lancet infectious diseases Issue: Volume 22:Issue 11(2022) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD®) Device, in Healthy Adult Subjects. Issue 3 (19th January 2019) Authors: Shrewsbury, Stephen B.; Jeleva, Maria; Satterly, Kelsey H.; Lickliter, Jason; Hoekman, John Journal: Headache Issue: Volume 59:Issue 3(2019) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Issue 9 (2nd September 2019) Authors: Manoff, Susan B.; Sausser, Michele; Falk Russell, Amy; Martin, Jason; Radley, David; Hyatt, Donna; Roberts, Christine C.; Lickliter, Jason; Krishnarajah, Janakan; Bett, Andrew; Dubey, Sheri; Finn, Tyler; Coller, Beth-Ann Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 9(2019) Page Start: 2195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers. Issue 4 (12th December 2016) Authors: Schluep, Thomas; Lickliter, Jason; Hamilton, James; Lewis, David L.; Lai, Ching‐Lung; Lau, Johnson YN; Locarnini, Stephen A.; Gish, Robert G.; Given, Bruce D. Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 4(2017) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PEGylated Carboxyhemoglobin Bovine (SANGUINATE): Results of a Phase I Clinical Trial. Issue 8 (12th August 2014) Authors: Misra, Hemant; Lickliter, Jason; Kazo, Friedericke; Abuchowski, Abraham Journal: Artificial organs Issue: Volume 38:Issue 8(2014:Aug.) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗